TXP Medical, Inc announced that it has received ¥1.5 billion in funding from ITOCHU Corporation, The University of Tokyo Edge Capital Partners Co., Ltd.
April 04, 2022
Share
TXP Medical, Inc announced that it has received approximately ¥1,500,000,000 in its series B round of funding on April 5, 2022. The company has issued common shares in the transaction. The transaction includes participation from new investor ITOCHU Corporation and existing investor The University of Tokyo Edge Capital Partners Co., Ltd.
Itochu Corporation is a diversified group organized around 8 areas of activity:
- distribution of food products (34.9% of net sales): frozen food, vegetable oil, sweeteners, sugars, etc.;
- distribution of hydrocarbons (23.3%): hydrocarbons (natural gas, oil products, bioethanol, etc.). The group also develops manufacturing of chemical products activity;
- manufacturing and sale of industrial and construction machines, vehicles and ships (9.7%);
- production of metals and coal (8.5%);
- sale of consumer products (8.4%). The group also develops forest products sale and real estate development activities;
- distribution of computing and telecommunication equipments (7%): data transmission, Internet access, media content broadcasting and mobile telephony equipments. The group also offers financial services;
- sale of textile products (3.6%);
- other (4.6%).
Net sales are distributed geographically as follows: Japan (79.5%), Singapore (5.4%), the United States (4.5%), Australia (3.1%), China (2.8%) and other (4.7%).
TXP Medical, Inc announced that it has received ¥1.5 billion in funding from ITOCHU Corporation, The University of Tokyo Edge Capital Partners Co., Ltd.
ITOCHU CORPORATION 
